staurosporine has been researched along with hymenialdisine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, K; Concepción, GP; Feldberg, LR; Greenstein, M; Harper, MK; Ireland, CM; Kim, SC; Mallon, R; Mangalindan, GC; Tasdemir, D; Wojciechowicz, D | 1 |
Flajolet, M; Greengard, P; Meijer, L | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Kato, M; Kawaguchi, M; Kojima, H; Nagano, T; Okabe, T; Tanaka, A; Terai, T; Tsuganezawa, K; Utata, R | 1 |
Jagarlapudi, SA; Sinha, BN; Tajne, S; Vadivelan, S | 1 |
Hoda, N; Maqbool, M; Mobashir, M | 1 |
Agrawal, K; Annadurai, N; Das, V; Džubák, P; Hajdúch, M | 1 |
3 review(s) available for staurosporine and hymenialdisine
Article | Year |
---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
Topics: Alzheimer Disease; Antigens, Bacterial; Azepines; Bacterial Proteins; Humans; Methylene Blue; Neurons; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyridines; Pyrroles; Staurosporine; tau Proteins | 2017 |
4 other study(ies) available for staurosporine and hymenialdisine
Article | Year |
---|---|
Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1).
Topics: Animals; Antineoplastic Agents; Azepines; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Philippines; Phosphorylation; Porifera; Protein Serine-Threonine Kinases; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
Topics: Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Evaluation, Preclinical; Fluorescence Polarization; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Kinetics; MAP Kinase Kinase Kinase 5; Models, Chemical; Molecular Conformation; Protein Binding; Protein Kinase Inhibitors; Spectrometry, Fluorescence; Staurosporine | 2008 |
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
Topics: Algorithms; Computer Simulation; Databases, Factual; Drug Design; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Models, Chemical; Models, Molecular; Molecular Structure; Oxazines; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Stereoisomerism; Structure-Activity Relationship | 2009 |